Dan Lemaitre - Aug 25, 2022 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Role
Director
Signature
/s/ Kelly G. Huller, Attorney-in-Fact
Stock symbol
GMED
Transactions as of
Aug 25, 2022
Transactions value $
$0
Form type
4
Date filed
1/18/2023, 03:55 PM
Previous filing
Jan 31, 2022
Next filing
Feb 27, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMED Stock Option (Right to Buy Class A Common Stock) Other $0 -2.25K -30% $0.00 5.25K Aug 25, 2022 Class A Common Stock 2.25K $12.59 Direct F1, F2
transaction GMED Stock Option (Right to Buy Class A Common Stock) Other $0 -3K -30% $0.00 7K Aug 25, 2022 Class A Common Stock 3K $23.95 Direct F1, F3
transaction GMED Stock Option (Right to Buy Class A Common Stock) Other $0 -4.5K -30% $0.00 10.5K Aug 25, 2022 Class A Common Stock 4.5K $24.10 Direct F1, F4
transaction GMED Stock Option (Right to Buy Class A Common Stock) Other $0 -6K -30% $0.00 14K Aug 25, 2022 Class A Common Stock 6K $25.52 Direct F1, F5
transaction GMED Stock Option (Right to Buy Class A Common Stock) Other $0 -7.5K -30% $0.00 17.5K Aug 25, 2022 Class A Common Stock 7.5K $26.27 Direct F1, F6
transaction GMED Stock Option (Right to Buy Class A Common Stock) Other $0 -7.5K -30% $0.00 17.5K Aug 25, 2022 Class A Common Stock 7.5K $43.77 Direct F1, F7
transaction GMED Stock Option (Right to Buy Class A Common Stock) Other $0 -7.5K -30% $0.00 17.5K Aug 25, 2022 Class A Common Stock 7.5K $43.58 Direct F1, F8
transaction GMED Stock Option (Right to Buy Class A Common Stock) Other $0 -7.5K -30% $0.00 17.5K Aug 25, 2022 Class A Common Stock 7.5K $53.27 Direct F1, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option transfers reported in this Form 4 represent options to purchase Class A Common Stock that have been transferred to the reporting person's ex-spouse pursuant to an option transfer agreement in connection with a divorce settlement. The shares now owned by the ex-spouse are no longer beneficially owned by the reporting person.
F2 These options were granted on January 30, 2013 and are fully vested.
F3 These options were granted on January 23, 2014 and are fully vested.
F4 These options were granted on January 20, 2015 and are fully vested.
F5 These options were granted on January 25, 2016 and are fully vested.
F6 These options were granted on January 30, 2017 and are fully vested.
F7 These options were granted on January 22, 2018 and are fully vested.
F8 These options were granted on January 22, 2019 and are fully vested.
F9 These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.